DavidLichterMD

PubMed

• Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia.
  David G Lichter, Linda A Hershey> ;Neurology. 2023 Oct 10
• 12 citations
  Freezing of Gait in Parkinson's Disease: Risk Factors, Their Interactions, and Associated Nonmotor Symptoms.
  David Lichter, Ralph Holmes Boring Benedict, Linda A. Hershey> ;Parkinson's Disease. 2021 Jan 12
• 14 citations
  Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson's disease, mild cognitive impairment, Alzheimer's dis...
  Dejan Jakimovski, Niels Bergsland, Michael G. Dwyer, Jesper Hagemeier, Deepa P. Ramasamy, Kinga Szigeti, Thomas Guttuso, David Lichter, David Hojnacki, Bianca Weinstoc...> ;Neurobiology of Aging. 2020 Feb 8
• 38 citations
  Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease
  Niels Bergsland, Robert Zivadinov, Ferdinand Schweser, Jesper Hagemeier, David Lichter, Thomas Guttuso> ;Movement Disorders. 2019 Jul 1
• 20 citations
  Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium.
  Thomas Guttuso, Kelly Andrzejewski, David Lichter, Julie K. Andersen> ;Journal of the Neurological Sciences. 2019 Jul 15
• 43 citations
  Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease
  Thomas Guttuso, Niels Bergsland, Jesper Hagemeier, David Lichter, Ofer Pasternak, Robert Zivadinov> ;AJNR. American Journal of Neuroradiology. 2018 Feb 1
• 11 citations
  Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson’s Disease
  David Lichter, Ralph Holmes Boring Benedict, Linda A. Hershey> ;Journal of Parkinson's Disease. 2018 Jan 1
• 35 citations
  Influence of gender on Tourette syndrome beyond adolescence
  David Lichter, S.G. Finnegan> ;European Psychiatry. 2015 Feb 1
• 7 citations
  Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders
  Jesper Hagemeier, M. Heininen-Brown, Tereza Gabelić, Thomas Guttuso, N. Silvestri, David Lichter, L.E. Fugoso, Niels Bergsland, Ellen Carl, Jeroen J. G. Geurts, Bianca...> ;AJNR. American Journal of Neuroradiology. 2014 Oct 1
• 89 citations
  Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy
  George Mulligan, David I. Lichter, Alessandra Di Bacco, Stephen J. Blakemore, Allison Berger, Erik Koenig, Hugues Bernard, William L. Trepicchio, Bin Li, Rachel Neuwir...> ;Blood. 2014 Jan 30
• 3 citations
  Freezing of gait in PD has a REM correlate Twice cursed with a shared pathophysiology
  Linda A. Hershey, David Lichter> ;Neurology. 2013 Sep 17
• 53 citations
  Sequence analysis of β-subunit genes of the 20S proteasome in patients with relapsed multiple myeloma treated with bortezomib or dexamethasone.
  David I. Lichter, Hadi Danaee, Michael D. Pickard, Olga Tayber, Michael D. Sintchak, Hongliang Shi, Paul G. Richardson, Jamie Cavenagh, Joan Bladé, Thierry Facon, Rube...> ;Blood. 2012 Nov 29
• 8 citations
  Before chorea. Pre-Huntington mild cognitive impairment
  David Lichter, Linda A. Hershey> ;Neurology. 2010 Aug 10
• 39 citations
  Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 12-week interim analysis.
  Keith Edwards, Linda A. Hershey, Laura O. Wray, Edward M. Bednarczyk, David Lichter, Martin R. Farlow, Stewart D. Johnson> ;Dementia and Geriatric Cognitive Disorders. 2004 Jan 1
• 37 citations
  Pilot study of effect of emotional stimuli on tic severity in children with Tourette's syndrome
  Beatrice L. Wood, Kendra B. Klebba, Olufowbi Gbadebo, David Lichter, Roger Kurlan, Bruce L. Miller> ;Movement Disorders. 2003 Nov 1
• 1 citations
  To test or not to test? That is the question (with a twist)
  David Lichter, Anthony E. Lang> ;Neurology. 2000 May 9
• 21 citations
  Influence of family history on clinical expression of Tourette’s syndrome
  David Lichter, Jacek Dmochowski, Lisa A. Jackson, Kimberly S. Trinidad> ;Neurology. 1999 Jan 1
• 36 citations
  Slowed reaction time during a continuous performance test in children with Tourette's syndrome.
  David W. Shucard, Ralph H.B. Benedict, Ayda Tekok-Kilic, David Lichter> ;Neuropsychology. 1997 Jan 1
• 21 citations
  Predictors of Clonidine Response in Tourette Syndrome: Implications and Inferences
  David Lichter, Lisa A. Jackson> ;Journal of Child Neurology. 1996 Mar 1
• 12 citations
  Parkinsonism associated with fluoxetine and cimetidine: a case report.
  Raphael J. Leo, David Lichter, Linda A. Hershey> ;Journal of Geriatric Psychiatry and Neurology. 1995 Oct 1
• 41 citations
  Clinical evidence of genomic imprinting in Tourette's syndrome
  David Lichter, Lisa A. Jackson, Mark Schachter> ;Neurology. 1995 May 1
• 31 citations
  Micrographia with cognitive dysfunction: “Minimal” sequelae of a putaminal infarct
  P. Pullicino, David Lichter, Ralph H.B. Benedict> ;Movement Disorders. 1994 Jan 1
• 26 citations
  Tremor at Onset: Predictor of Cognitive and Motor Outcome in Parkinson's Disease?
  Linda A. Hershey, Brian J. Feldman, Kye Y. Kim, Chris Commichau, David Lichter> ;Archives of Neurology. 1991 Oct 1
• 31 citations
  Carbamazepine-induced tics.
  Roger Kurlan, Jonathan Kersun, Jill Behr, Adrian Leibovici, Pierre N. Tariot, David Lichter, Ira Shoulson> ;Clinical Neuropharmacology. 1989 Aug 1
• 89 citations
  Sensory tics in Tourette's syndrome
  Roger Kurlan, David Lichter, David J. Hewitt> ;Neurology. 1989 May 1
• Join now to see all

Journal Articles

• Substance use disorder in adult Tourette syndrome: frequency, profile and co-morbidities. Mind and Brain  
  Lichter, DG, The Journal of Psychiatry, 7/1/2011
• Before chorea: Pre-Huntington mild cognitive impairment.  
  Lichter DG, Hershey LA, Neurology, 1/1/2010
• Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open label study.  
  Edwards K, Royall D, Hershey L, Lichter D, Hake A, Farlow M, Pasquier F, Johnson S, Dement Geriatr Cogn Disord, 1/1/2007
• Cognitive and behavioral changes in progressive supranuclear palsy.  
  Hershey LA, Lichter DG, MedLink Neurology, 1/1/2006
• Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 12-week interim analysis.  
  Edwards KR, Hershey L, Wray L, Bednarczyk EM, Lichter D, Farlow M, Johnson S, Dement Geriatr Cogn Disord, 1/1/2004
• A pilot study of the effect of emotional stimuli on tic severity in children with Tourette Syndrome.  
  Wood BL, Klebba K, Gbadebo O, Lichter D, Kurlan R, and Miller B, Movement Disorders, 1/1/2003
• To test or not to test? That is the question (with a twist).  
  Lichter DG, Lang AE, Neurology, 1/1/2000
• Influence of family history on clinical expression of Tourette Syndrome.  
  Lichter DG, Dmochowski J, Jackson LA, Trinidad KS, Neurology, 1/1/1999
• Carotid Endarterectomy (ACE) Trial collaborators: Low-dose high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomized controlled trial.  
  Taylor DW, Barnett HJM, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes R, Spence JD, Lancet, 1/1/1999
• Slowed reaction time during a continuous performance test in children with Tourette's syndrome.  
  Shucard DW, Benedict RHB, Tekok-Kilic A, Lichter D, Neuropsychology, 1/1/1997
• Predictors of Clonidine Response in Tourette Syndrome: Implications and Inferences.  
  Lichter DG, Jackson LA, J. Child Neurol, 1/1/1996
• Clinical evidence of genomic imprinting in Tourette's syndrome.  
  Lichter DG, Jackson LA. Schacter M, Neurology, 1/1/1995
• Parkinsonism associated with fluoxetine and cimetidine: a case report.  
  Leo RJ, Lichter DG, Hershey LA, J. Geriatr Psychiatry Neurol, 1/1/1995
• Levodopa drug holiday versus drug dosage reduction in Parkinson's disease?  
  Kurlan R, Tanner CM, Goetz C, Sutton J, Lichter D, et al, Clinical Neuropharmacology, 1/1/1994
• Micrographia with cognitive dysfunction: "Minimal" sequelae of a putaminal infarct.  
  Pullicino P, Lichter D, Benedict R, Movement Disorders, 1/1/1994
• Tremor at onset: Predictor of cognitive and motor outcome in Parkinson's disease?  
  Hershey LA, Feldman BJ, Kim KY, Lein C, Lichter DG, Arch Neurol, 1/1/1991
• Sensory Tics in Tourette's Syndrome  
  Kurlan R, Lichter D, Hewitt D, Neurology, 1/1/1989
• Carbamazepine-induced Tics.  
  Kurlan R, Kersun J, Behr J, Leibovici A, Tariot P, Lichter D, Shoulson I, Clinical Neuropharmacology, 1/1/1989
• Erratic Gastric Emptying of Levodopa May Cause "Random" Oscillations of Parkinsonian Mobility  
  Kurlan R, Rothfield K, Woodward W, Nutt J, Miller C, Lichter D, Shoulson I, Neurology, 1/1/1988
• Duodenal and Gastric Delivery of Levodopa in Parkinsonism  
  Kurlan R, Nutt JG, Woodward WR, Rothfield K, Lichter D, Miller C, Carter JH, Shoulson I, Ann. Neurol., 1/1/1988
• Cognitive and Motor Dysfunction in Parkinson's disease: Clinical, Performance and CT correlations.  
  Lichter DG, Corbett AJ, Fitzgibbon GN et al, Arch Neurol, 1/1/1988
• Opiate Withdrawal Unmasks Tourette's Syndrome.  
  Lichter DG, Majumdar L, Kurlan R, Clinical Neuropharmacology, 1/1/1988
• Join now to see all

Books/Book Chapters

• Behavioral Neurology and Neuropsychiatry 
  Chapter: Frontal-Subcortical Circuits 
  Page 59 - 87Lichter, DGEditors: Arciniegas DB, Anderson CA, Filley CM.Cambridge University Press, Cambridge, UK2013
• "MedLink Neurology+C233" 
  Chapter: Cognitive and behavioral changes in progressive supranuclear palsy. 
  Page 1 - 18Hershey LA, Bharucha KJ, Lichter DGEditors: S. Gilman.Medlink Corporation, San Diego, CA2011
• "MedLink Neurology" 
  Chapter: Cognitive and behavioral changes in progressive supranuclear palsy. 
  Page 1 - 13Hershey LA, Lichter DEditors: S. Gilman.Medlink Corporation, San Diego, CA2007
• "Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders" 
  Editors: Lichter DG, Cummings JL.Guilford Press, New York, NY2001
• Frontal-Subcortical Circuits in Psychiatric and Neurological Disorders 
  Chapter: Introduction and Overview 
  Page 1 - 43Lichter DG, Cummings JL, Mega MEditors: Lichter DG and Cummings JL.Guilford Press, New York, NY2001
• Frontal-Subcortical Circuits in Psychiatric and Neurological disorders. 
  Chapter: Movement Disorders 
  Page 260 - 313Lichter DG, Cummings JL, Mega MEditors: Lichter DG and Cummings JL.Guilford Press, New York, NY2001
• Frontal-Subcortical Circuits in Psychiatric and Neurological disorders. 
  Chapter: Addictions and Frontal-Subcortical Circuits 
  Page 231 - 259Lichter DG, Cummings JL, Mega MEditors: Lichter DG and Cummings JL.Guilford Press, New York, NY2001
• Clinical Neurology 
  Chapter: Current Therapy 
  Page 1 - 35Kingston N, Goodman A, Moss A, Lichter DGEditors: AB Baker, RJ Joynt.Harper and Row, Philadelphia, PA1989
• Practice of Geriatrics 
  Chapter: Parkinson's Disease and Parkinsonian Syndromes 
  Page 336 - 349Lichter DGEditors: Duthie Jr EH and Katz R. Eds.R..W.B. Saunders Co., Orlando, FLEdition 3,1988
• Join now to see all

Abstracts/Posters

• Diagnostic and prognostic issues in adolescents with psychogenic tics.
  Lichter DG, Finnegan SG, Movement Disorders, 1/1/2012
• Paroxysmal non-kinesigenic dyskinesia, dystonia and gait disorder secondary to mild GLUT1 deficiency.
  Finnegan SG, Lichter DG, Movement Disorders, 1/1/2011
• Major determinants of psychosocial and occupational disability in adult Tourette syndrome.
  Lichter DG, Finnegan SG, Movement Disorders, 1/1/2010
• Substance use disorder in adult Tourette syndrome
  Lichter, DG, Movement Disorders, 1/1/2009
• Female gender is an independent predictor of tic severity in adult Tourette syndrome.
  Lichter, DG, Neurology, 1/1/2008
• Memantine may alleviate psychosis and cognitive dysfunction in dementia with Lewy bodies.
  Lichter DG, Wray L, Hershey LA, Movement Disorders, 1/1/2006
• Brain metabolic and clinical response to galantamine in dementia with Lewy bodies (DLB): A preliminary report.
  Lichter DG, Marton K, Bednarczyk EM, Wray L, Wack D, Hershey LA, Movement Disorders, 1/1/2004
• "Galantamine in the management of dementia with Lewy bodies".
  Lichter, DG with Dr. Edwards, American Psychiatric Association (APA) 156th Annual Meeting, San Francisco, CA, 5/17/2003
• "Depression and recovery after acute ischemic stroke: initial data on lacunar versus other stroke types".
  Lichter, DG with Drs. Baker, Hershey and Gresham, Rotman Institute Brain/Behavior Meeting, Toronto, CA, 3/1/2002
• Discrete influences on executive function in Tourette syndrome
  Lichter DG, Jackson LA, Bisker SM, Neurology, 1/1/2002
• Relative course of tics and behavioral symptoms in Tourette's syndrome.
  Lichter DG, Diegelman NM, Bisker SE, Jackson LA, Movement Disorders, 1/1/2001
• Risks of obsessive compulsive and self-injurious behaviors in Tourette syndrome.
  Lichter DG, Jackson LA, Trinidad KS, Neurology, 1/1/1998
• The relationship between Tourette's syndrome and "childhood schizophrenia."
  Lichter DG, Diegelman NM, Jackson LA., J. Neuropsychiatry Clin Neurosci, 1/1/1997
• Influence of family history on clinical expression of Tourette syndrome.
  Lichter DG, Jackson LA, Trinidad KS, Neurology, 1/1/1997
• Genomic imprinting in Tourette's syndrome
  Lichter DG, Jackson LA, Schachter M, Neurology, 1/1/1997
• Bilineal contributions to obsessive-compulsive behavior in Tourette's syndrome.
  Lichter DG, Diegelman NM, Jackson LA, Trinidad KS, J. Neuropsychiatry Clin Neurosci, 1/1/1997
• Predictors of neuroleptic requirement following clonidine trial in Tourette syndrome.
  Lichter DG, Trinidad K, Jackson LA, Neurology, 1/1/1996
• Allergies and Tourette's syndrome.
  Feigin A, Robertson M, Trinidad K, Lichter D, et al, Neurology, 1/1/1996
• "Usefulness of eight oculomotor signs in distinguishing early PSP from PD".
  Lichter, DG, with L.A. Hershey, 12th Annual Oculomotor Symposium, Washington, DC, 10/1/1995
• Longitudinal assessment of verbal and visual memory in Parkinson's disease patients.
  Donnelly KZ, Donnelly JP, Lichter DG, Hershey LA, Arch Clinical Neuropsychol, 1/1/1995
• Executive dysfunction in Tourette syndrome: clinical correlates
  Lichter DG, Jackson LA, Schacter M, Neurology, 1/1/1995
• "Usefulness of SPECT in distinguishing progressive supranuclear palsy from Parkinson's disease."
  Lichter, DG, with L.A. Hershey, 3rd International Congress of Movement Disorders, Orlando, FL, 11/1/1994
• Usefulness of SPECT in distinguishing progressive supranuclear palsy from Parkinson's disease.
  Hershey LA, Gona G, Husain S, Pares G, Spain J, Donnelly K, Olszewski W, Lichter D, Movement Disorders, 1/1/1994
• Childhood Tourette syndrome phenotype is influenced by gender of affected parent.
  Lichter DG, Stofko P, Jackson L, Schacter M, Neurology, 1/1/1993
• Blood pressure correlates and predictors of Clonidine response in Tourette Syndrome
  Lichter DG, Movement Disorders, 1/1/1992
• Join now to see all

Lectures

• "Female gender and adult Tourette Syndrome". 
  Movement disorder Society's 17th International Congress on Parkinson's Disease and Movement disorde - 6/16/2013
• "Diagnostic and prognostic issues in adolescents with psychogenic tics". 
  Movement Disorder Society's 16th International Congress of Parkinson's Disease and Movement Disorde - 6/17/2012
• "Parkinson's Disease: Clinical features, differential diagnosis and management". 
  CME lecture, WCA Hospital, Jamestown, NY - 10/5/2011
• "Paroxysmal non-kinesigenic dyskinesia, dystonia and gait disorder secondary to mild GLUT1 deficiency". 
  Movement Disorder Society's 15th International Congress of Parkinson's Disease and Movement Disorder - 6/5/2011
• "The Faces and Cases of Parkinson's Disease: Exploring the Challenges of Management of Early and Advanced Parkinson's Disease". 
  CME lecture (Center for Medical Knowledge), Rochester, NY - 9/1/2010
• "Major determinants of psychosocial and occupational disability in adult Tourette syndrome": 
  Movement Disorder Society's 14th International Congress of Parkinson's Disease and Movement Disorder - 6/13/2010
• "Low-dose naltrexone's tolerability and effects in fatigued patients with Parkinson's disease: an open-label study". 
  American Society for Experimental NeuroTherapeutics, Washington, DC - 3/1/2010
• "Shifting paradigms in the diagnosis and treatment of Parkinson's disease". 
  CME program, Bethlehem, PA - 11/4/2009
• "Substance use disorder in adult Tourette syndrome". 
  Movement Disorder Society's 13th International Congress of Parkinson's Disease and Movement Disorde - 6/7/2009
• "Restless legs syndrome: epidemiologic, genetic, pathophysiologic and clinical aspects" 
  Grand Rounds, Albany Medical Center, Albany, NY - 3/26/2009
• "Parkinson's Disease Advanced Therapeutic Strategies (PATHS)" 
  National CME program (NCME), Buffalo, NY - 5/13/2008
• "Female gender is an independent predictor of tic severity in adult Tourette syndrome". 
  60th Annual Meeting of the American Academy of Neurology, Chicago, NY - 4/12/2008
• "New options for the treatment of restless legs syndrome". 
  Visiting Speaker's Program, Boehringer-Ingelheim Pharmaceuticals, Bradford, PA - 9/18/2007
• "Current approaches in treating Parkinson's disease". 
  American Health Resources PharmEd CE Program, Buffalo, NY - 6/1/2007
• "Restless legs syndrome". 
  Neurology Grand Rounds, Buffalo, NY; Visiting Speaker's Program, Boehringer-Ingelheim Pharmaceutical - 4/1/2007
• "Memantine may alleviate psychosis and cognitive dysfunction in dementia with Lewy bodies". 
  World Parkinson Congress, Washington, D.C. - 2/22/2006
• "Tourette Syndrome: Current and Experimental Therapy". 
  9th International Congress of Parkinson's Disease and Movement Disorders, New Orleans, USA; Neurolo - 3/5/2005
• "Parkinson's disease: Where are we? Where are we headed?" 
  Visiting Speaker's Program, Boehringer-Ingelheim/Pfizer Pharmaceuticals, Buffalo, NY - 3/1/2005
• "Parkinson's disease: current approaches to management". 
  Visiting Speaker's Program, Boehringer-Ingelheim/Pfizer Pharmaceuticals, Rochester, NY - 10/1/2004
• "Brain metabolic and clinical response to galantamine in dementia with Lewy bodies (DLB): A preliminary report". 
  8th International Congress of Parkinson's Disease and Movement Disorders, Rome, Italy - 6/13/2004
• "Tourette Syndrome: Neurobiology and Management". 
  Neurology Grand Rounds, Buffalo, NY; 8th International Congress of Parkinson's Disease and Movement - 2/1/2004
• "Galantamine is safe and effective in patients with dementia with Lewy bodies (DLB)". 
  3rd International Workshop on dementia with Lewy Bodies and Parkinson's Disease with Dementia (DLB/P - 9/17/2003
• "Results of a 24-week, open-label, flexible-dose trial to assess the safety and efficacy of galantamine in patients with dementia with Lewy bodies: an Interim analysis". 
  6th International Conference on Alzheimer's and Parkinson's Disease (AD/PD), Seville, Spain - 5/8/2003
• "Dementia with Lewy bodies: Interim analysis from the galantamine trial". 
  Neurology Grand Rounds, Buffalo, NY - 1/1/2003
• "Discrete influences on executive function in Tourette syndrome". 
  54th Annual Meeting of the American Academy of Neurology, Denver, CO - 4/1/2002
• Join now to see all

Other

• In-service training videotape for educators of children with Tourette Syndrome 
  Lichter, DG, S. Conners and R. Fisher-Collins, TSA National Board, and D. Pandolfino, Videotapes
  Manhattan Transfer Video Production Studios, Manhattan, NY - 1/1/1995